nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—ABCC1—Dactinomycin—ocular cancer	0.307	0.35	CbGbCtD
Lamivudine—ABCG2—Dactinomycin—ocular cancer	0.205	0.234	CbGbCtD
Lamivudine—ABCC2—Carboplatin—ocular cancer	0.153	0.174	CbGbCtD
Lamivudine—ABCG2—Carboplatin—ocular cancer	0.138	0.157	CbGbCtD
Lamivudine—ABCB1—Dactinomycin—ocular cancer	0.074	0.0844	CbGbCtD
Lamivudine—NME2—pineal body—ocular cancer	0.00708	0.23	CbGeAlD
Lamivudine—PGK1—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.00589	0.0633	CbGpPWpGaD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—ID2—ocular cancer	0.00434	0.0466	CbGpPWpGaD
Lamivudine—NME1-NME2—eye—ocular cancer	0.00392	0.128	CbGeAlD
Lamivudine—NT5C—eye—ocular cancer	0.00364	0.118	CbGeAlD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—E2F3—ocular cancer	0.00337	0.0362	CbGpPWpGaD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—ID2—ocular cancer	0.00329	0.0353	CbGpPWpGaD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—CDC25A—ocular cancer	0.00321	0.0345	CbGpPWpGaD
Lamivudine—NT5C—lymphoid tissue—ocular cancer	0.00256	0.0833	CbGeAlD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—E2F3—ocular cancer	0.00256	0.0275	CbGpPWpGaD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—CDC25A—ocular cancer	0.00243	0.0261	CbGpPWpGaD
Lamivudine—NME2—eye—ocular cancer	0.00215	0.0699	CbGeAlD
Lamivudine—NME2—retina—ocular cancer	0.00213	0.0692	CbGeAlD
Lamivudine—NME2—epithelium—ocular cancer	0.00197	0.0639	CbGeAlD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—E2F2—ocular cancer	0.00187	0.0201	CbGpPWpGaD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—CCND2—ocular cancer	0.00182	0.0196	CbGpPWpGaD
Lamivudine—PGK1—HIF-2-alpha transcription factor network—EP300—ocular cancer	0.00168	0.018	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—E2F3—ocular cancer	0.00162	0.0174	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—RBBP4—ocular cancer	0.00162	0.0174	CbGpPWpGaD
Lamivudine—NME1—lymphoid tissue—ocular cancer	0.00161	0.0522	CbGeAlD
Lamivudine—CMPK1—lymphoid tissue—ocular cancer	0.00155	0.0504	CbGeAlD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—CDC25A—ocular cancer	0.00154	0.0166	CbGpPWpGaD
Lamivudine—NME2—lymphoid tissue—ocular cancer	0.00151	0.0492	CbGeAlD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—TFDP1—ocular cancer	0.00151	0.0162	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00148	0.0159	CbGpPWpGaD
Lamivudine—ABCC1—Sphingosine 1-phosphate (S1P) pathway—GNA11—ocular cancer	0.00148	0.0159	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00145	0.0156	CbGpPWpGaD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—CCND2—ocular cancer	0.00138	0.0148	CbGpPWpGaD
Lamivudine—ABCC1—Sphingosine 1-phosphate (S1P) pathway—GNAQ—ocular cancer	0.00138	0.0148	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—CCND3—ocular cancer	0.00137	0.0147	CbGpPWpGaD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—CDK4—ocular cancer	0.00122	0.0131	CbGpPWpGaD
Lamivudine—NME1—E-cadherin signaling in the nascent adherens junction—CCND1—ocular cancer	0.00112	0.012	CbGpPWpGaD
Lamivudine—DCK—retina—ocular cancer	0.00108	0.0353	CbGeAlD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.00104	0.0112	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—CDK6—ocular cancer	0.00102	0.0109	CbGpPWpGaD
Lamivudine—PGK1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000986	0.0106	CbGpPWpGaD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—CDK4—ocular cancer	0.000925	0.00995	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PSPH—ocular cancer	0.000914	0.00982	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PSPH—ocular cancer	0.000914	0.00982	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PSPH—ocular cancer	0.000914	0.00982	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—HDAC1—ocular cancer	0.000876	0.00942	CbGpPWpGaD
Lamivudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.000866	0.00931	CbGpPWpGaD
Lamivudine—DCK—lymphoid tissue—ocular cancer	0.000771	0.0251	CbGeAlD
Lamivudine—PGK1—Metabolism—PSPH—ocular cancer	0.000745	0.00801	CbGpPWpGaD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—EP300—ocular cancer	0.000726	0.0078	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—E2F1—ocular cancer	0.000721	0.00775	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PSPH—ocular cancer	0.000693	0.00744	CbGpPWpGaD
Lamivudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.000645	0.00694	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PSPH—ocular cancer	0.000634	0.00681	CbGpPWpGaD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—MYC—ocular cancer	0.000632	0.0068	CbGpPWpGaD
Lamivudine—NME1—E-cadherin signaling in the nascent adherens junction—AKT1—ocular cancer	0.000623	0.0067	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.000622	0.00668	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00061	0.00656	CbGpPWpGaD
Lamivudine—PGK1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000596	0.0064	CbGpPWpGaD
Lamivudine—PGK1—Disease—SAG—ocular cancer	0.000589	0.00633	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.000588	0.00631	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.000563	0.00605	CbGpPWpGaD
Lamivudine—NME1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—ocular cancer	0.000561	0.00603	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00056	0.00602	CbGpPWpGaD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—EP300—ocular cancer	0.00055	0.00591	CbGpPWpGaD
Lamivudine—PGK1—Disease—E2F5—ocular cancer	0.000522	0.00561	CbGpPWpGaD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—TP53—ocular cancer	0.000519	0.00558	CbGpPWpGaD
Lamivudine—PGK1—Disease—E2F4—ocular cancer	0.000511	0.00549	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.000511	0.00549	CbGpPWpGaD
Lamivudine—PGK1—Disease—RPL39—ocular cancer	0.000501	0.00539	CbGpPWpGaD
Lamivudine—PGK1—Disease—RBL1—ocular cancer	0.000501	0.00539	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000483	0.00519	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PSPH—ocular cancer	0.00048	0.00516	CbGpPWpGaD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—MYC—ocular cancer	0.000479	0.00515	CbGpPWpGaD
Lamivudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.000468	0.00503	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000457	0.00491	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.000436	0.00468	CbGpPWpGaD
Lamivudine—PGK1—Disease—TFDP1—ocular cancer	0.000404	0.00434	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.000398	0.00427	CbGpPWpGaD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—TP53—ocular cancer	0.000394	0.00423	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.000379	0.00408	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.000367	0.00394	CbGpPWpGaD
Lamivudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.000349	0.00375	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000339	0.00364	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PSPH—ocular cancer	0.000329	0.00354	CbGpPWpGaD
Lamivudine—PGK1—Disease—MAML2—ocular cancer	0.000321	0.00345	CbGpPWpGaD
Lamivudine—ABCC3—Fluoropyrimidine Activity—TP53—ocular cancer	0.000315	0.00339	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000309	0.00332	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.000304	0.00327	CbGpPWpGaD
Lamivudine—ABCB1—retina—ocular cancer	0.000298	0.0097	CbGeAlD
Lamivudine—ABCG2—HIF-2-alpha transcription factor network—EP300—ocular cancer	0.000296	0.00319	CbGpPWpGaD
Lamivudine—ABCC4—Fluoropyrimidine Activity—TP53—ocular cancer	0.000296	0.00318	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000295	0.00317	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—GNA11—ocular cancer	0.000288	0.00309	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—GNA11—ocular cancer	0.000288	0.00309	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—GNA11—ocular cancer	0.000288	0.00309	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000285	0.00307	CbGpPWpGaD
Lamivudine—ABCB1—epithelium—ocular cancer	0.000275	0.00896	CbGeAlD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000271	0.00292	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.000271	0.00291	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—GNAQ—ocular cancer	0.000267	0.00287	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—GNAQ—ocular cancer	0.000267	0.00287	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—GNAQ—ocular cancer	0.000267	0.00287	CbGpPWpGaD
Lamivudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.000252	0.00271	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.000252	0.0027	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.00025	0.00269	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000237	0.00254	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000236	0.00254	CbGpPWpGaD
Lamivudine—PGK1—Disease—HDAC1—ocular cancer	0.000235	0.00252	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—GNA11—ocular cancer	0.000234	0.00252	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00022	0.00237	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—GNA11—ocular cancer	0.000218	0.00234	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—GNAQ—ocular cancer	0.000218	0.00234	CbGpPWpGaD
Lamivudine—ABCG2—Fluoropyrimidine Activity—TP53—ocular cancer	0.000217	0.00233	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.000216	0.00232	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000216	0.00232	CbGpPWpGaD
Lamivudine—ABCB1—lymphoid tissue—ocular cancer	0.000212	0.0069	CbGeAlD
Lamivudine—PGK1—Disease—CDKN2B—ocular cancer	0.00021	0.00226	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PSPH—ocular cancer	0.000208	0.00223	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—GNAQ—ocular cancer	0.000203	0.00218	CbGpPWpGaD
Lamivudine—NME2—Metabolism—GNA11—ocular cancer	0.000199	0.00214	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000194	0.00209	CbGpPWpGaD
Lamivudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000193	0.00207	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PSPH—ocular cancer	0.000191	0.00205	CbGpPWpGaD
Lamivudine—NME2—Metabolism—GNAQ—ocular cancer	0.000185	0.00199	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—TGFB1—ocular cancer	0.000177	0.0019	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000174	0.00187	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	0.000169	0.00181	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000164	0.00176	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000164	0.00176	CbGpPWpGaD
Lamivudine—NME1—Metabolism—GNA11—ocular cancer	0.000151	0.00162	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PSPH—ocular cancer	0.00015	0.00161	CbGpPWpGaD
Lamivudine—NME1—Metabolism—GNAQ—ocular cancer	0.00014	0.00151	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—GNA11—ocular cancer	0.000139	0.0015	CbGpPWpGaD
Lamivudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.000136	0.00146	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PSPH—ocular cancer	0.000132	0.00142	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PSPH—ocular cancer	0.00013	0.0014	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—GNAQ—ocular cancer	0.00013	0.00139	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PSPH—ocular cancer	0.000122	0.00131	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SAG—ocular cancer	0.000118	0.00127	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HDAC1—ocular cancer	0.000117	0.00126	CbGpPWpGaD
Lamivudine—PGK1—Disease—MDM2—ocular cancer	0.000117	0.00125	CbGpPWpGaD
Lamivudine—ABCC3—NRF2 pathway—TGFB1—ocular cancer	0.000116	0.00125	CbGpPWpGaD
Lamivudine—ABCC4—Ectoderm Differentiation—MYC—ocular cancer	0.000115	0.00123	CbGpPWpGaD
Lamivudine—ABCC4—NRF2 pathway—TGFB1—ocular cancer	0.00011	0.00118	CbGpPWpGaD
Lamivudine—PGK1—Disease—CDKN1B—ocular cancer	0.000107	0.00114	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000105	0.00113	CbGpPWpGaD
Lamivudine—ABCC1—Disease—E2F5—ocular cancer	0.000105	0.00113	CbGpPWpGaD
Lamivudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000104	0.00112	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GNA11—ocular cancer	0.000104	0.00111	CbGpPWpGaD
Lamivudine—ABCC1—Disease—E2F4—ocular cancer	0.000103	0.0011	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RPL39—ocular cancer	0.000101	0.00108	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RBL1—ocular cancer	0.000101	0.00108	CbGpPWpGaD
Lamivudine—PGK1—Disease—CDKN1A—ocular cancer	9.83e-05	0.00106	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GNAQ—ocular cancer	9.63e-05	0.00104	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—EP300—ocular cancer	9.61e-05	0.00103	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—EP300—ocular cancer	9.61e-05	0.00103	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—EP300—ocular cancer	9.61e-05	0.00103	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	9.43e-05	0.00101	CbGpPWpGaD
Lamivudine—PGK1—Disease—EP300—ocular cancer	9.35e-05	0.00101	CbGpPWpGaD
Lamivudine—ABCC2—NRF2 pathway—TGFB1—ocular cancer	9.23e-05	0.000992	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	9.06e-05	0.000973	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—MDM2—ocular cancer	8.86e-05	0.000953	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	8.31e-05	0.000893	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—CDK2—ocular cancer	8.3e-05	0.000892	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—MDM2—ocular cancer	8.26e-05	0.000888	CbGpPWpGaD
Lamivudine—PGK1—Disease—MYC—ocular cancer	8.15e-05	0.000876	CbGpPWpGaD
Lamivudine—PGK1—Disease—TGFB1—ocular cancer	8.13e-05	0.000874	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TFDP1—ocular cancer	8.12e-05	0.000873	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	7.86e-05	0.000845	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—EP300—ocular cancer	7.83e-05	0.000842	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—EP300—ocular cancer	7.28e-05	0.000783	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	7.17e-05	0.000771	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PSPH—ocular cancer	7.13e-05	0.000766	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—TGFB1—ocular cancer	7.1e-05	0.000763	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—MDM2—ocular cancer	6.79e-05	0.00073	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	6.78e-05	0.000728	CbGpPWpGaD
Lamivudine—NME2—Metabolism—EP300—ocular cancer	6.66e-05	0.000716	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GNA11—ocular cancer	6.54e-05	0.000703	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAML2—ocular cancer	6.45e-05	0.000693	CbGpPWpGaD
Lamivudine—PGK1—Disease—HRAS—ocular cancer	6.4e-05	0.000688	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—MDM2—ocular cancer	6.33e-05	0.00068	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GNAQ—ocular cancer	6.08e-05	0.000654	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GNA11—ocular cancer	6.02e-05	0.000646	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—AKT1—ocular cancer	5.81e-05	0.000624	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—AKT1—ocular cancer	5.81e-05	0.000624	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—AKT1—ocular cancer	5.81e-05	0.000624	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	5.7e-05	0.000612	CbGpPWpGaD
Lamivudine—PGK1—Disease—AKT1—ocular cancer	5.65e-05	0.000608	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GNAQ—ocular cancer	5.59e-05	0.000601	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—AKT1—ocular cancer	5.46e-05	0.000587	CbGpPWpGaD
Lamivudine—NME1—Metabolism—EP300—ocular cancer	5.05e-05	0.000543	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	5.02e-05	0.00054	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—HRAS—ocular cancer	4.86e-05	0.000523	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—AKT1—ocular cancer	4.73e-05	0.000509	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HDAC1—ocular cancer	4.72e-05	0.000507	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GNA11—ocular cancer	4.71e-05	0.000507	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—EP300—ocular cancer	4.66e-05	0.000501	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	4.59e-05	0.000493	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—HRAS—ocular cancer	4.53e-05	0.000487	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.51e-05	0.000485	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—AKT1—ocular cancer	4.4e-05	0.000473	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GNAQ—ocular cancer	4.38e-05	0.000471	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	4.38e-05	0.00047	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	4.23e-05	0.000455	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN2B—ocular cancer	4.23e-05	0.000454	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GNA11—ocular cancer	4.15e-05	0.000446	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GNA11—ocular cancer	4.1e-05	0.000441	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TGFB1—ocular cancer	4.05e-05	0.000435	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	4.03e-05	0.000433	CbGpPWpGaD
Lamivudine—NME2—Metabolism—AKT1—ocular cancer	4.03e-05	0.000433	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GNAQ—ocular cancer	3.86e-05	0.000414	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GNA11—ocular cancer	3.83e-05	0.000411	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GNAQ—ocular cancer	3.82e-05	0.00041	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—HRAS—ocular cancer	3.73e-05	0.000401	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GNAQ—ocular cancer	3.56e-05	0.000382	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.54e-05	0.00038	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	3.51e-05	0.000377	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	3.5e-05	0.000376	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—HRAS—ocular cancer	3.47e-05	0.000373	CbGpPWpGaD
Lamivudine—DCK—Metabolism—EP300—ocular cancer	3.46e-05	0.000372	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—ocular cancer	3.34e-05	0.000358	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HRAS—ocular cancer	3.19e-05	0.000343	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—ocular cancer	3.05e-05	0.000328	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	2.88e-05	0.00031	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—ocular cancer	2.82e-05	0.000303	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	2.43e-05	0.000262	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MDM2—ocular cancer	2.35e-05	0.000252	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GNA11—ocular cancer	2.24e-05	0.000241	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—EP300—ocular cancer	2.19e-05	0.000235	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1B—ocular cancer	2.14e-05	0.00023	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—ocular cancer	2.09e-05	0.000225	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GNAQ—ocular cancer	2.08e-05	0.000224	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—EP300—ocular cancer	2.01e-05	0.000216	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1A—ocular cancer	1.98e-05	0.000212	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EP300—ocular cancer	1.88e-05	0.000202	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—ocular cancer	1.64e-05	0.000176	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TGFB1—ocular cancer	1.63e-05	0.000176	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—EP300—ocular cancer	1.57e-05	0.000169	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—EP300—ocular cancer	1.39e-05	0.000149	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—EP300—ocular cancer	1.37e-05	0.000147	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—ocular cancer	1.32e-05	0.000142	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HRAS—ocular cancer	1.29e-05	0.000138	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—EP300—ocular cancer	1.28e-05	0.000137	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—ocular cancer	1.21e-05	0.000131	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—ocular cancer	1.14e-05	0.000122	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—ocular cancer	9.52e-06	0.000102	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—ocular cancer	8.37e-06	9e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—ocular cancer	8.29e-06	8.91e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—ocular cancer	7.72e-06	8.3e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—EP300—ocular cancer	7.49e-06	8.05e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—ocular cancer	4.53e-06	4.87e-05	CbGpPWpGaD
Lamivudine—Phlebitis—Carboplatin—ocular cancer	1.77e-06	0.0792	CcSEcCtD
Lamivudine—Raised liver function tests—Dactinomycin—ocular cancer	1.69e-06	0.0756	CcSEcCtD
Lamivudine—Folliculitis—Dactinomycin—ocular cancer	1.24e-06	0.0555	CcSEcCtD
Lamivudine—Hepatomegaly—Dactinomycin—ocular cancer	1.1e-06	0.0493	CcSEcCtD
Lamivudine—Infection—Carboplatin—ocular cancer	7.45e-07	0.0333	CcSEcCtD
Lamivudine—Aplastic anaemia—Dactinomycin—ocular cancer	7.33e-07	0.0328	CcSEcCtD
Lamivudine—Mouth ulceration—Dactinomycin—ocular cancer	7.06e-07	0.0316	CcSEcCtD
Lamivudine—Sepsis—Dactinomycin—ocular cancer	6.77e-07	0.0303	CcSEcCtD
Lamivudine—Phlebitis—Dactinomycin—ocular cancer	6.58e-07	0.0294	CcSEcCtD
Lamivudine—Pain—Carboplatin—ocular cancer	6.42e-07	0.0287	CcSEcCtD
Lamivudine—Body temperature increased—Carboplatin—ocular cancer	5.93e-07	0.0265	CcSEcCtD
Lamivudine—Liver function test abnormal—Dactinomycin—ocular cancer	5.23e-07	0.0234	CcSEcCtD
Lamivudine—Aspartate aminotransferase increased—Dactinomycin—ocular cancer	5.1e-07	0.0228	CcSEcCtD
Lamivudine—Dysphagia—Dactinomycin—ocular cancer	4.9e-07	0.0219	CcSEcCtD
Lamivudine—Pancytopenia—Dactinomycin—ocular cancer	4.65e-07	0.0208	CcSEcCtD
Lamivudine—Neutropenia—Dactinomycin—ocular cancer	4.58e-07	0.0205	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Dactinomycin—ocular cancer	4.33e-07	0.0194	CcSEcCtD
Lamivudine—Stomatitis—Dactinomycin—ocular cancer	4.26e-07	0.019	CcSEcCtD
Lamivudine—Agranulocytosis—Dactinomycin—ocular cancer	4.08e-07	0.0182	CcSEcCtD
Lamivudine—Hepatitis—Dactinomycin—ocular cancer	3.92e-07	0.0175	CcSEcCtD
Lamivudine—Pharyngitis—Dactinomycin—ocular cancer	3.89e-07	0.0174	CcSEcCtD
Lamivudine—Erythema multiforme—Dactinomycin—ocular cancer	3.71e-07	0.0166	CcSEcCtD
Lamivudine—Chills—Dactinomycin—ocular cancer	3.52e-07	0.0157	CcSEcCtD
Lamivudine—Alopecia—Dactinomycin—ocular cancer	3.46e-07	0.0155	CcSEcCtD
Lamivudine—Erythema—Dactinomycin—ocular cancer	3.41e-07	0.0153	CcSEcCtD
Lamivudine—Ill-defined disorder—Dactinomycin—ocular cancer	3.17e-07	0.0142	CcSEcCtD
Lamivudine—Anaemia—Dactinomycin—ocular cancer	3.15e-07	0.0141	CcSEcCtD
Lamivudine—Malaise—Dactinomycin—ocular cancer	3.08e-07	0.0138	CcSEcCtD
Lamivudine—Leukopenia—Dactinomycin—ocular cancer	3.05e-07	0.0137	CcSEcCtD
Lamivudine—Myalgia—Dactinomycin—ocular cancer	2.91e-07	0.013	CcSEcCtD
Lamivudine—Discomfort—Dactinomycin—ocular cancer	2.87e-07	0.0128	CcSEcCtD
Lamivudine—Oedema—Dactinomycin—ocular cancer	2.79e-07	0.0125	CcSEcCtD
Lamivudine—Infection—Dactinomycin—ocular cancer	2.77e-07	0.0124	CcSEcCtD
Lamivudine—Thrombocytopenia—Dactinomycin—ocular cancer	2.73e-07	0.0122	CcSEcCtD
Lamivudine—Anorexia—Dactinomycin—ocular cancer	2.66e-07	0.0119	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Dactinomycin—ocular cancer	2.54e-07	0.0113	CcSEcCtD
Lamivudine—Decreased appetite—Dactinomycin—ocular cancer	2.42e-07	0.0108	CcSEcCtD
Lamivudine—Fatigue—Dactinomycin—ocular cancer	2.4e-07	0.0107	CcSEcCtD
Lamivudine—Pain—Dactinomycin—ocular cancer	2.38e-07	0.0106	CcSEcCtD
Lamivudine—Feeling abnormal—Dactinomycin—ocular cancer	2.3e-07	0.0103	CcSEcCtD
Lamivudine—Gastrointestinal pain—Dactinomycin—ocular cancer	2.28e-07	0.0102	CcSEcCtD
Lamivudine—Body temperature increased—Dactinomycin—ocular cancer	2.2e-07	0.00984	CcSEcCtD
Lamivudine—Abdominal pain—Dactinomycin—ocular cancer	2.2e-07	0.00984	CcSEcCtD
Lamivudine—Hypersensitivity—Dactinomycin—ocular cancer	2.05e-07	0.00917	CcSEcCtD
Lamivudine—Asthenia—Dactinomycin—ocular cancer	2e-07	0.00893	CcSEcCtD
Lamivudine—Diarrhoea—Dactinomycin—ocular cancer	1.91e-07	0.00852	CcSEcCtD
Lamivudine—Vomiting—Dactinomycin—ocular cancer	1.77e-07	0.00792	CcSEcCtD
Lamivudine—Rash—Dactinomycin—ocular cancer	1.76e-07	0.00785	CcSEcCtD
Lamivudine—Nausea—Dactinomycin—ocular cancer	1.65e-07	0.0074	CcSEcCtD
